BUY Shilpa Medicare Limited — Prakash Gaba
byPrakash GabaHorizon: NA (inferred Swing (≤2wk))23 Oct 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
RSI at 25 — oversold territory
Technicals · rsi·23 Oct · today
AGES Austria issues GMP certification to Shilpa Medicare’s Jadcherla unit
NewsCnbc-Tv18·10 Oct · 2w ago
Nothing found in this tip’s window yet.
MACD below its signal line — bearish momentum
Technicals · macd·23 Oct · today
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Shilpa Medicare
- BUY — Chandan Taparia, Motilal Oswal1 Oct 2026 · ~3 months · target ₹1,220 · SL hit
- BUY — Sumeet Bagadia, Choice Broking3 Sept 2026 · ~2 weeks · target ₹1,010 · Expired
- BUY — Kunal Hasmukhlal Shah1 Sept 2026 · ~3 months · target ₹950 · Target hit
- BUY — Rajesh Agarwal, AUM Capital31 Aug 2026 · ~1 year · target ₹1,100 · Active
- BUY — Vishnu Kant Upadhyay, Master Capital Services5 Aug 2026 · ~3 months · target ₹680 · Target hit
More from Prakash Gaba
- SELL Ather Energy23 Oct 2026 · Same day · target ₹1,380 · Target hit
- BUY UltraTech Cement23 Oct 2026 · Same day · target ₹11,200 · SL hit
- BUY The Indian Hotels Company22 Oct 2026 · Next day · target ₹800 · SL hit
- BUY Orient Cement22 Oct 2026 · ~2 weeks · target ₹120 · SL hit
- SELL Coforge22 Oct 2026 · ~2 weeks · target ₹1,870 · SL hit

